Bridgefront Capital’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,777
Closed -$355K 823
2024
Q4
$355K Buy
+16,777
New +$440K 0.12% 308
2024
Q3
Sell
-11,245
Closed -$268K 695
2024
Q2
$268K Buy
+11,245
New +$289K 0.11% 330
2021
Q3
Sell
-3,257
Closed -$217K 627
2021
Q2
$217K Buy
+3,257
New +$177K 0.08% 479

Other funds holding SGRY

Bridgefront Capital's SGRY Position: Q1 2025 in Review

Bridgefront Capital sold out of Surgery Partners (SGRY) in Q1 2025, closing a stake of 16,777 shares — an estimated $355K sold.

Bridgefront Capital first reported a position in SGRY in Q2 2021 and held it in 3 quarters. The position peaked at $355K in Q4 2024. 208 funds tracked by Wall St. Rank hold SGRY as of Q1 2025.

  • Bridgefront Capital reported no remaining Surgery Partners position as of Q1 2025 after selling out during the quarter.
  • Bridgefront Capital sold 16,777 Surgery Partners shares in Q1 2025, an estimated $355K.
  • Bridgefront Capital first reported a position in Surgery Partners in Q2 2021 and held it in 3 quarters.
  • Bridgefront Capital's Surgery Partners position peaked at $355K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2025.

Based on Bridgefront Capital's 13F filing for Q1 2025, filed 15 May 2025.